Therapy of Feto-Placental Insufficiency

1. Front Matter

   Pages I-XV

   PDF

2. 1st Session

   1. Plasma Oestriol in Obstetric Disease

      • A. Klopper, G. Masson

      Pages 1-9

   2. Validity of Cardiotocography in the Control of Feto-Placental Insufficiency. Preliminary Results

      • G. Agostoni, A. Longatti, A. Parini, F. Scapin, L. De Vito, F. Pianetti

      Pages 10-17

   3. The Diagnosis of “Small for Dates” Babies by the Cytological Examination of the Amniotic Fluid

      • N. S. Athanassiades, A. S. Vrettos, C. Koliopoulos, P. P. Panayotou

      Pages 18-20

   4. The Value of the Atropine Test in Therapeutic Orientation during Feto-Placental Insufficiency

      • G. Brunel, J. L. Vinkler

      Pages 21-23

   5. Assessment of the Value of Hormonal Assays and Ultrasonic Measurements in the Management of Placental Insufficiency

      • R. C. Chef, M. J. Bouche

      Pages 24-29

   6. Human Placental Lactogen as an Index of Placental Function: Plasma Measurements in Normal and Pathological Pregnancies

      • G. Culucci, G. C. Englaro, G. C. Tosolini, F. Di Chiara, E. Desole, L. Franzolini

      Pages 30-34

   7. Human Choriogonadotropin, Choriosomatomammotrophin and Fetal Nutrition

      • P. G. Crosignani

      Pages 35-36

   8. The Clinical Value of the Placenta Lactogen in the Monitoring of Feto-Placental Disfunction

      • F. W. Dittmar, P. Tykal, W. Schmidt

      Pages 37-40

   9. Amniotic Fluid Analysis in Placental Insufficiency

      • A. Drařančić, Jasna Ivić, I. Kuvačić

      Pages 41-47

   10. Thermostable Alkaline Phosphatases in Feto-Placental Insufficiency

       • J. Gombert, J. R. Giraud, X. Bareau, D. Reiss

       Pages 48-52

   11. The Insulin Tolerance Test (I.T.T.) as a Basis for the Therapy of Placental Insufficiency

       • S. Friedman, J. A. Goldman

       Pages 53-54

   12. Radioimmunologic Determination of Plasma Estriol in Pregnancy with a Specific Antiserum to Estriol

       • H. J. Künzig, W. Geiger

       Pages 55-59

   13. Some Parameters of Feto-Placental Insufficiency

       • F. Santi, G. M. Lamedica, G. Rossi, M. Scafidi, E. Porro

       Pages 60-66

   14. Urinary Estriol as a Therapeutic Guide of Feto-Placental Failure in the Vasculo-Renal Hypertensive Syndrome of Pregnancy

       • A. P. Mirescu

       Pages 67-67

   15. Diagnosis of Fetal Maturity by Biochemical and Cytological Studies

       • F. Santi, G. M. Lamedica, E. Cevasco, L. Ambrosini, E. Porro

       Pages 68-71

   16. Radioimmunological Determination of Human Placental Lactogen (HPL), Cystynyloaminopeptidase (CAP) and Daily Excretion of Urinary Oestriol in the Diagnosis of Chronic Placental Insufficiency

       • A. Cekański, P. Skalba

       Pages 72-74

   17. Oestriol as Guide in the Treatment of Feto-Placental Insufficiency: Possibilities and Limits

       • P. Spanio, G. P. Mandruzzato, M. C. Sabbati, F. Nisi, M. Macchia, C. Persello

       Pages 75-77

   18. The Comparative Studies about the Estriol and HPL Production Rate in the Risk-Pregnancies

       • P. Tykal, F. W. Dittmar, L. Schapher

       Pages 78-82

3. 2nd Session

   1. The Pathology of Feto-Placental Insufficiency in Hypertensive Pregnancy

      • W. B. Robertson, I. A. Brosens, H. G. Dixon

      Pages 83-97

The progess in biological sciences and its applications in obstetrics in the last twenty years have formed the base for feto-placental semeiotics. In this way, it has been possible to diagnose placental insufficiency even in patients whose clinical conditions gave all the indications of a perfectly normal feto-placental condition. On the other hand, observations have shown that in certain conditions some deficiencies can im­ prove until normality is reached again. On the basis of the above one feels justified to talk about the therapy of feto-placental insufficiency. Until now this therapy has been aimed at the obstetrical pathology of the mother. Our aim is to illustrate the various steps which should be taken to execute an efficient therapy of the conditions relating to the pathology of the fetus, realizing full well that fetal pharmacology is only now being taken into consideration. The various steps to be taken, the length of therapy, and all the other correlated factors are still the object of individual ex­ periences, and we are fortunate to have amongst us researchers in this field who have accepted our invitation and can supply us with their personal experiences which can also be compared. The first international symposium on the therapy of feto-placental insufficiency has been organized in conjunction with the Samil-Pabyrn Foundation whom I would lik to thank, and especially so its president, Mrs. INGE SAXON-MILLS.

• diagnosis
• fetus
• obstetrics
• pathology
• placenta
• therapy

• Istituto di Clinica Ostetrica e Ginecologica, Parma, Italy

  Bruno Salvadori

Policies and ethics